Press Release: Geneos : Geneos Therapeutics Announces Positive Clinical Data for Personalized Therapeutic Cancer Vaccines in Ongoing Liver Cancer Trial

--Overall Response Rate 30.4 Percent in 23 Evaluable Patients Including Two Complete Responses and a Third Cancer-Free Patient-- --Vaccination-Related Adverse Events Limited to Grades 1 and 2 Only-- --100 Percent of Patients Analyzed Mount Tumor-Infiltrating CD4+ & CD8+ T Cells in...